Skip to main content

Table 2 Factors associated with the development of hepatotoxicity (Bivariate analysis)

From: Drug-induced hepatotoxicity among TB/HIV co-infected patients in a referral hospital, Ethiopia

NoVariableP valueOR95% CI
1BMI (18.6–24.9 kg m2)1Reference
BMI (< 18.5 kg m2)0.0036.648(1.941–22.771)
2Alcohol history (no)1Reference
Yes0.0284.023(1.165–13.885
3Type of TB (PTB)0.0111Reference
Extra pulmonary0.0194.487(1.286–15.655)
Disseminated0.0118.333(1.642–42.283)
4WHO clinical staging (3)1Reference
Stage 40.0025.844(1.865–18.314)
5OI- prophylaxis (no)0.0641Reference
CPT0.4012.537(0.289–22.226)
CPT and INH0.0668.0(0.872–73.397)
6Adherence (good)0.0271Reference
Fair0.0583.545(0.958–13.128)
Poor0.0098.125(1.689–39.085)
7Viral load (undetected)1Reference
Detected0.0203.750(1.226–11.468)